ADT	Androgen Deprivation Therapy
ARTA	Androgen Receptor-Targeting Agent
Fig	Figure
G	Grade
HV	High Volume
LV	Low Volume
mHSPC	Metastatic Hormone-Sensitive Prostate Cancer
M1a	Presence of metastases in non-regional lymph nodes
M1b	Presence of bone metastases
M1c	Presence of metastases in viscera
OS	Overall Survival
PC	Prostate Cancer
PSA	Prostate Specific Antigen
PFS	Progression-Free Survival
rPFS	Radiographic Progression-Free Survival
SBRT	Stereotactic Body Radiation Therapy